After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
SYRE belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Spyre Therapeutics Inc is $2.62B. A total of 0.6 million shares were traded on the day, compared to an average of 771.68K shares.
In the most recent transaction, Turtle Cameron sold 15,000 shares of SYRE for 30.68 per share on Jan 02 ’26. After the transaction, the Chief Executive Officer now owns 671,907 company shares. In a previous transaction on Dec 01 ’25, Turtle Cameron sold 15,000 shares at 29.02 per share. SYRE shares that Chief Executive Officer owns now total 686,907.
Among the insiders who sold shares, Turtle Cameron disposed of 45,000 shares on Nov 03 ’25 at a per-share price of $23.33. This resulted in the Chief Executive Officer holding 701,907 shares of SYRE after the transaction. In another insider transaction, CAMERON TURTLE bought 90,000 shares at $24.46 per share on Nov 03 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SYRE has a high of $35.31 and a low of $10.91.
As of this writing, SYRE has an earnings estimate of -$0.79 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$1.84. The company reported an EPS of -$0.81 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SYRE’s latest balance sheet shows that the firm has $93.13M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $20.14M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $83.94M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
